UY29400A1 - Base libre de lercanidipina. - Google Patents
Base libre de lercanidipina.Info
- Publication number
- UY29400A1 UY29400A1 UY29400A UY29400A UY29400A1 UY 29400 A1 UY29400 A1 UY 29400A1 UY 29400 A UY29400 A UY 29400A UY 29400 A UY29400 A UY 29400A UY 29400 A1 UY29400 A1 UY 29400A1
- Authority
- UY
- Uruguay
- Prior art keywords
- free base
- lercanidipine free
- lercanidipine
- purity
- formulation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicinal Preparation (AREA)
- Pyridine Compounds (AREA)
Abstract
La invención proporciona una base libre de lercanidipina sustancialmente pura, que tiene una pureza de por lo menos 95%, preferentemente por lo menos aproximadamente 97%, más preferentemente por lo menos aproximadamente 99%, y aun más preferentemente por lo menos aproximadamente 99,5%. La base libre de lercanidipina de la presente invención es formada como un sólido amorfo que es fácillmente manipulado y particularmente adecuado para la formulacinon de composiciones farmacéuticas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US65674105P | 2005-02-25 | 2005-02-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY29400A1 true UY29400A1 (es) | 2006-06-30 |
Family
ID=36587241
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY29400A UY29400A1 (es) | 2005-02-25 | 2006-02-24 | Base libre de lercanidipina. |
Country Status (18)
Country | Link |
---|---|
US (1) | US20060199849A1 (es) |
EP (1) | EP1853562A1 (es) |
JP (1) | JP2008531516A (es) |
KR (1) | KR20070105978A (es) |
CN (1) | CN101142186A (es) |
AR (1) | AR053023A1 (es) |
AU (1) | AU2006218027A1 (es) |
BR (1) | BRPI0608136A2 (es) |
CA (1) | CA2597992A1 (es) |
EA (1) | EA200701686A1 (es) |
IL (1) | IL184348A0 (es) |
MX (1) | MX2007010362A (es) |
NO (1) | NO20074873L (es) |
PE (1) | PE20061393A1 (es) |
TW (1) | TW200640860A (es) |
UY (1) | UY29400A1 (es) |
WO (1) | WO2006089788A1 (es) |
ZA (1) | ZA200708126B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100651212B1 (ko) * | 2004-10-27 | 2006-12-01 | 제일약품주식회사 | 무정형 레르카니디핀의 제조방법 |
WO2008040367A1 (en) * | 2006-08-01 | 2008-04-10 | Union Quimico-Farmaceutica S.A. | Lercanidipine hydrobromide, a process for its preparation, crystalline forms and compositions thereof |
DE102010005124A1 (de) * | 2010-01-19 | 2012-03-01 | Stada Arzneimittel Ag | Feste pharmazeutische Zusammensetzung umfassend Lercanidipin |
CN102531999B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 无定形盐酸乐卡地平及其制备方法 |
CN102558032B (zh) * | 2011-12-16 | 2014-02-26 | 华润赛科药业有限责任公司 | 一种无定形盐酸乐卡地平及其制备方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8403866D0 (en) * | 1984-02-14 | 1984-03-21 | Recordati Chem Pharm | Diphenylalkylaminoalkyl esters |
US5912351A (en) * | 1995-05-12 | 1999-06-15 | Recordati, S.A. Chemical And Pharmaceutical Company | Anhydrous 1,4-Dihydropyridines and salts thereof |
IT1275532B (it) * | 1995-07-14 | 1997-08-07 | Recordati Chem Pharm | Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa |
US5696139A (en) * | 1995-05-12 | 1997-12-09 | Recordati S.A., Chemical And Pharmaceutical Company | Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure |
IT1298732B1 (it) * | 1998-03-13 | 2000-02-02 | Recordati Chem Pharm | Composizioni farmaceutiche orali assumibili senza liquidi,contenenti complessi di inclusione |
US6852737B2 (en) * | 2001-08-06 | 2005-02-08 | Recordati Ireland Limited | Crude and crystalline forms of lercanidipine hydrochloride |
US20030069285A1 (en) * | 2001-08-06 | 2003-04-10 | Recordati Ireland Limited | Novel solvate and crystalline forms of lercanidipine hydrochloride |
US20030180355A1 (en) * | 2001-10-16 | 2003-09-25 | Amedeo Leonardi | Combination therapy for hypertension |
US20040147566A1 (en) * | 2002-10-16 | 2004-07-29 | Amedeo Leonardi | Lisinopril/lercanidipine combination therapy |
WO2004035051A1 (en) * | 2002-10-16 | 2004-04-29 | Recordati Ireland Limited | Lisinopril/lercanidipine combination therapy |
US20040198789A1 (en) * | 2003-02-28 | 2004-10-07 | Recordati Ireland Limited | Lercanidipine/ARB/diuretic therapeutic combinations |
CA2547657A1 (en) * | 2003-12-01 | 2005-06-16 | Lifecycle Pharma A/S | Pharmaceutical compositions comprising lercanidipine |
TW200613275A (en) * | 2004-08-24 | 2006-05-01 | Recordati Ireland Ltd | Lercanidipine salts |
TW200616681A (en) * | 2004-10-05 | 2006-06-01 | Recordati Ireland Ltd | Lercanidipine capsules |
-
2006
- 2006-02-22 AR ARP060100640A patent/AR053023A1/es not_active Application Discontinuation
- 2006-02-24 AU AU2006218027A patent/AU2006218027A1/en not_active Abandoned
- 2006-02-24 CN CNA2006800055031A patent/CN101142186A/zh active Pending
- 2006-02-24 KR KR1020077017757A patent/KR20070105978A/ko not_active Application Discontinuation
- 2006-02-24 PE PE2006000225A patent/PE20061393A1/es not_active Application Discontinuation
- 2006-02-24 UY UY29400A patent/UY29400A1/es unknown
- 2006-02-24 EP EP06723129A patent/EP1853562A1/en not_active Withdrawn
- 2006-02-24 BR BRPI0608136-3A patent/BRPI0608136A2/pt not_active Application Discontinuation
- 2006-02-24 TW TW095106335A patent/TW200640860A/zh unknown
- 2006-02-24 JP JP2007556566A patent/JP2008531516A/ja not_active Withdrawn
- 2006-02-24 CA CA002597992A patent/CA2597992A1/en not_active Abandoned
- 2006-02-24 MX MX2007010362A patent/MX2007010362A/es not_active Application Discontinuation
- 2006-02-24 EA EA200701686A patent/EA200701686A1/ru unknown
- 2006-02-24 WO PCT/EP2006/001783 patent/WO2006089788A1/en active Application Filing
- 2006-02-27 US US11/364,861 patent/US20060199849A1/en not_active Abandoned
-
2007
- 2007-07-02 IL IL184348A patent/IL184348A0/en unknown
- 2007-09-21 ZA ZA200708126A patent/ZA200708126B/xx unknown
- 2007-09-25 NO NO20074873A patent/NO20074873L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CN101142186A (zh) | 2008-03-12 |
EA200701686A1 (ru) | 2008-02-28 |
PE20061393A1 (es) | 2007-01-16 |
WO2006089788A1 (en) | 2006-08-31 |
NO20074873L (no) | 2007-11-22 |
ZA200708126B (en) | 2008-11-26 |
US20060199849A1 (en) | 2006-09-07 |
MX2007010362A (es) | 2007-10-17 |
IL184348A0 (en) | 2007-10-31 |
TW200640860A (en) | 2006-12-01 |
BRPI0608136A2 (pt) | 2009-11-17 |
EP1853562A1 (en) | 2007-11-14 |
JP2008531516A (ja) | 2008-08-14 |
CA2597992A1 (en) | 2006-08-31 |
AU2006218027A1 (en) | 2006-08-31 |
AR053023A1 (es) | 2007-04-18 |
KR20070105978A (ko) | 2007-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1122861T1 (el) | Φαρμακευτικες συνθεσεις της αμορφης μορφης ν-[2,4-δις(1,1-διμεθυλαιθυλ)-5-υδροξυφαινυλ]-1,4-διυδρο-4-οξοκινολινο-3-καρβοξαμιδιου | |
UY29401A1 (es) | Clorhidato de lercanidipina amorfo. | |
CL2017001847A1 (es) | Una formulación sólida de dosificación farmacéutica | |
BRPI0509184A (pt) | composições farmacêuticas | |
ATE528989T1 (de) | Kristalline feste rasagilin-base | |
CR10528A (es) | Proceso para producir poxvirus y composiciones de poxvirus | |
AR058753A1 (es) | Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol | |
GT200800276A (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
CR11316A (es) | Derivado de uracilo o timina para el tratamiiento de la hepatitis c. | |
PA8660301A1 (es) | Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion | |
AR050254A1 (es) | Intermediarios y procesos para preparar dichos intermediarios utiles en la fabricacion de pirrolotriazinas | |
CU20060153A7 (es) | Nueva forma cristalina v de agomelatina, procedimiento para su preparación y composiciones farmacéuticas que las contienen | |
ATE465719T1 (de) | Oral zerfallende zusammensetzung von olanzapin oder donepezil | |
PA8846901A1 (es) | Inhibidores de cinasa akt y p70 s6. | |
UY30778A1 (es) | Compuestos de 5,6-dihidro-1h-piridin-2-ona | |
CL2009000281A1 (es) | Compuestos derivados de 5,6-dihidro-pirrolo-[2,1-a]-isoquinolinas y pirrolo-[2,1-a]-isoquinolinas; composicion farmaceutica que comprende a dichos compuestos; y uso para el tratamaiento de trastornos de la fertilidad. | |
ECSP088635A (es) | Formulaciones orales que comprenden tigeciclina | |
BRPI0713031B8 (pt) | composto de di-hidro-piran-2-ona, composição farmacêutica, e uso dos mesmos | |
UY29400A1 (es) | Base libre de lercanidipina. | |
BRPI0408895A (pt) | formulações de cladribina para administração oral e transmucosal aperfeiçoada | |
BRPI0419195A (pt) | composição de lactato de mentila e uma mistura de isÈmeros de mentol | |
UY30023A1 (es) | Nueva asociacion de un inhibidor de la corriente sinusal i, y de un inhibidor calcico y las composiciones farmaceuticas que la contienen | |
GT200600010A (es) | Procedimientos para la preparacion de alcoholes aminoetoxibencilicos | |
GT200800066A (es) | Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento. | |
BR0117191A (pt) | Composições nanoparticuladas de isotretinoina |